文献速递产科母胎医学

哪种早孕期子痫前期风险评估方法最合适?一项基于模型的影响研究

Which first-trimester risk assessment method for preeclampsia is most suitable? A model-based impact study.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-04-14

本研究构建决策分析模型,在10万名孕妇的假设人群中比较EXPECT算法模型、NICE风险因素清单和FMF预测模型联合低剂量阿司匹林治疗与不进行风险评估的成本与收益。结果显示三种方法子痫前期发生率分别为1.98%、2.55%和1.90%,均低于不评估的3.00%,人均净财务收益分别为144欧元、43欧元和38欧元。

要点

  • EXPECT和FMF模型预防子痫前期的病例数相当,均优于NICE模型和不进行风险评估。
  • EXPECT模型资源需求最低、成本节约最高,但需要阿司匹林治疗的妇女人数最多。
  • 选择策略时需权衡成本节约、易用性与过度治疗程度,低剂量阿司匹林在孕期无明显劣势。

核心结论

  • EXPECT和FMF模型在预防子痫前期病例数方面相当,均优于NICE模型和不进行风险评估。
  • EXPECT模型资源需求较低且成本节约最高,但需要阿司匹林治疗的妇女人数也最多。
  • 选择策略时需权衡成本节约和易用性与过度治疗程度,尽管低剂量阿司匹林在孕期无明显劣势。

研究设计与样本

  • 构建决策分析模型,在10万名孕妇的假设人群中估计各策略的子痫前期病例数和成本。
  • 比较EXPECT算法预测模型、NICE风险因素清单和FMF预测模型联合低剂量阿司匹林治疗与不进行风险评估。
  • 进行单因素敏感性分析评估依从率对模型结果的影响。

主要发现

  • EXPECT、NICE和FMF模型组子痫前期发生率分别为1.98%、2.55%和1.90%,不评估组为3.00%。
  • EXPECT、NICE和FMF模型相对于不评估的人均净财务收益分别为144欧元、43欧元和38欧元。
  • 三种风险评估方法接受阿司匹林治疗的妇女比例分别为18.6%、10.2%和6.0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-dose aspirin treatment reduces the risk of preeclampsia among high-risk pregnant women. Internationally, several first-trimester risk-calculation methods are applied. OBJECTIVE: This study aimed to assess the costs and benefits of different first-trimester preeclampsia risk estimation algorithms: EXPECT (an algorithmic prediction model based on maternal characteristics), National Institute for Health and Care Excellence (a checklist of risk factors), and the Fetal Medicine Foundation (a prediction model using additional uterine artery Doppler measurement and laboratory testing) models, coupled with low-dose aspirin treatment, in comparison with no risk assessment. STUDY DESIGN: We constructed a decision analytical model estimating the number of cases of preeclampsia with each strategy and the costs of risk assessment for preeclampsia and early aspirin treatment, expressed in euros (€) in a hypothetical population of 100,000 women. We performed 1-way sensitivity analyses to assess the impact of adherence rates on model outcomes. RESULTS: Application of the EXPECT, National Institute for Health and Care Excellence, and Fetal Medicine Foundation models results in respectively 1.98%, 2.55%, and 1.90% of the women developing preeclampsia, as opposed to 3.00% of women in the case of no risk assessment. Overall, the net financial benefits of the EXPECT, National Institute for Health and Care Excellence, and Fetal Medicine Foundation models relative to no risk assessment are €144, €43, and €38 per patient, respectively. The respective percentages of women receiving aspirin treatment are 18.6%, 10.2%, and 6.0% for the 3 risk assessment methods. CONCLUSION: The EXPECT and Fetal Medicine Foundation model are comparable with regard to numbers of prevented preeclampsia cases, and both are superior to the National Institute for Health and Care Excellence model and to no risk assessment. EXPECT is less resource-demanding and results in the highest cost savings, but also requires the highest number of women to be treated with aspirin. When deciding which strategy is preferable, cost savings and easier use have to be weighed against the degree of overtreatment, although low-dose aspirin has no clear disadvantages during pregnancy.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Strijbos LTM, Hendrix MLE, Al-Nasiry S, et al. Which first-trimester risk assessment method for preeclampsia is most suitable? A model-based impact study. Am J Obstet Gynecol MFM. 2023. PMID: 37062507. doi:10.1016/j.ajogmf.2023.100974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。